Skip to main content

Time and geographical variations in utilization of endocrine therapy for breast cancer in Australia

Buy Article:

$51.00 plus tax (Refund Policy)


Background: Endocrine therapies, aromatase inhibitors and tamoxifen, are commonly used as an adjuvant treatment in women with breast cancer.

Keywords: Australia; aromatase inhibitors; breast cancer; drug use; tamoxifen

Document Type: Research Article


Affiliations: 1: Quality Use of Medicines and Pharmacy Research Centre, Sansom Institute 2: School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, South Australia, Australia

Publication date: 2011-02-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more